Investment
Features
FeesSafety
Academy
More
Pluang+

Two Bitcoin wallets dormant for 12+ years moved $33.85M in BTC, signaling early investor activity.

Market News
19 Oct 2026
Zycrypto
View Source
Bullish
Two Bitcoin wallets dormant for 12+ years moved $33.85M in BTC, signaling early investor activity.

Two Bitcoin wallets inactive for over 12 years recently transferred a combined total of 417 BTC, worth about $33.85 million. These wallets originally acquired Bitcoin when prices were around $127 and $355, showing massive gains. While it's unclear if the owners plan to sell or just moved the coins, this activity highlights early investor movements amid generally declining selling pressure from newer holders. Bitcoin's price remains stable around $82,146, with market data suggesting accumulation rather than widespread selling.

Regarding the recent movement of long-dormant Bitcoin wallets, here is Pluang's market snapshot as of Oct 19, 2026 18:21 WIB: Among 50 major cryptocurrencies priced on Pluang, 23 rose and 25 fell today. Notable movers include CRV (Curve DAO Token) at Rp6.334 with a 1-day change of +3.99% and a typical hold time of 62 days, showing 43% sell and 57% buy activity; ONE (Harmony) at Rp25 down 3.64%, with 52% sell and 48% buy; and ZIL (Zilliqa) at Rp40 down 3.07%, with 30% sell and 70% buy order activity.

More News

Lexeo Therapeutics to host event on clinical measures in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics to host event on clinical measures in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics announced an educational event on October 21, 2026, focusing on clinical endpoints and outcome measures in PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM). The event will feature discussions by Lexeo's Chief Medical Officer and a lea...

Others
Neutral
1 hour ago
EyePoint's DURAVYU misses primary endpoint in wet AMD trial but shows reduced treatment burden and safety.

EyePoint's DURAVYU misses primary endpoint in wet AMD trial but shows reduced treatment burden and safety.

EyePoint announced that its DURAVYU treatment for wet age-related macular degeneration (wet AMD) did not meet the primary goal of matching the visual improvement of the standard aflibercept treatment in the LUCIA Phase 3 trial. However, DURAVYU demon...

Company Fundamentals
Neutral
1 hour ago
Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.

Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.

Marker Therapeutics has been awarded a $2.6 million grant from the FDA's Orphan Products Clinical Trials program to support a Phase 1 study of its MT-601 multi-antigen recognizing T cell therapy for locally advanced unresectable pancreatic cancer. Th...

Market News
Bullish
1 hour ago
Agility Robotics appoints Mark Vale as audit committee chair ahead of public listing.

Agility Robotics appoints Mark Vale as audit committee chair ahead of public listing.

Agility Robotics announced that Mark Vale, former UPS president and current CEO of Transportation Insight, will join its board and chair the audit committee after its merger with Churchill Capital Corp XI. Vale's extensive experience in global logist...

Company Fundamentals
Bullish
1 hour ago
JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026

JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026

JazzCash, Pakistan's leading digital financial services platform, won the Silver Award in the Banking – InsurTech category at Money20/20 USA 2026 for its health-protection platform Sehat+. This platform provides affordable health insurance to Pakista...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App